Newborn blood spot screening – knowledge of genetic testing among mothers

Authors

  • Angeline David Medical College of Wisconsin, Milwaukee, USA
  • Meredith O. Cruz Medical College of Wisconsin, Milwaukee, USA
  • Grzegorz Telega Medical College of Wisconsin, Milwaukee, USA
  • Pippa Simpson Medical College of Wisconsin, Milwaukee, USA
  • Amy Pan Medical College of Wisconsin, Milwaukee, USA
  • Małgorzata Nagórska Medical College of Rzeszow University, Rzeszow, Poland https://orcid.org/0000-0002-3229-1186

DOI:

https://doi.org/10.15584/ejcem.2023.1.7

Keywords:

newborn, newborn blood spot screening, screening, perinatal care

Abstract

Introduction and aim. Newborn blood spot screening (NBS) uses genetic technology to screen for selected genetic, endocrine, and metabolic disorders. The purpose of the study was to assess the knowledge of newborn blood spot genetic screening among expectant mothers.

Material and methods. Between October 2015 and January 2016, a 20 question, multiple-choice questionnaire was administered to expectant mothers presenting for a pre-natal ultrasound at the Maternal Fetal Care Center in Milwaukee, Wisconsin Froedtert Hospital. Statistical analysis used Chi-Square or Fisher’s exact test for categorical variables.

Results. 103 women completed the survey; 34% believed that education regarding screening is incomplete and 39% believed that it needs improvement. 27% knew the purpose of newborn screening.

Conclusion. Many mothers lack general and specific knowledge about NBS and the diseases screened for. Health education that provides accurate and complete information on the newborn blood spot screening should be provided to all parents prior to the administering of any genetic testing. Key areas that should be targeted include: purpose of NBS, screened diseases and how to interpret the results of the test.

Downloads

Download data is not yet available.

References

Newborn Screening Frequently Asked Questions (FAQ). 2016. Retrieved August 20, 2016, from Wisconsin State Laboratory of Hygiene, http://www.slh.wisc.edu/clinical/newborn/parents-guide-to-newborn-screening/frequently-asked-questions-faqs/ Accessed August 19, 2022.

Detmar S, Hosli E, Dijkstra N, et al. Information and informed consent for neonatal screening: Opinions and preferences of parents. Birth. 2007;34(3):238-244. doi: 10.1111/j.1523-536x.2007.00176.x.

Nicholls SG. Proceduralisation, choice and parental reflections on decisions to accept newborn bloodspot screening. Journal of Medical Ethics. 2011;38(5):299-303. doi: 10.1136/medethics-2011-100040.

The President's Council on Bioethics. The changing moral focus of newborn screening: An ethical analysis by the president's council on bioethics. https://bioethicsarchive.georgetown.edu/pcbe/reports/newborn_screening/chapter4.html Accessed August 19, 2022.

Michie S, Dormandy E, Marteau TM. Informed choice: understanding knowledge in the context of screening uptake. Patient Educ Couns. 2003;50(3):247-253. doi: 10.1016/s0738-3991(03)00044-2.

Marteau TM, Dormandy E. Facilitating informed choice in prenatal testing: how well are we doing? Am J Med Genet. 2001;106(3):185-190. doi: 10.1002/ajmg.10006.

Baumiller RC, Cunningham G, Fisher N, et al. Code of ethical principles for genetics professionals: an explication. Am J Med Genet. 1996;65(3):179-183. doi: 10.1002/(SICI)1096-8628(19961028)65:3<179::AID-AJMG2>3.0.CO;2-L.

Statham H, Green J, Snowdon C. Mothers' consent to screening newborn babies for disease. BMJ. 1993;306(6881):858-859. doi: 10.1136/bmj.306.6881.858-c.

Davis TC, Humiston SG, Arnold CL, et al. Recommendations for effective newborn screening communication: results of focus groups with parents, providers, and experts. Pediatrics. 2006;117(5/2):326-340. doi: 10.1542/peds.2005-2633M.

Holtzman NA, Faden R, Chwalow AJ, et al. Effect of informed parental consent on mothers’ knowledge of newborn screening. Pediatrics. 1983;72(6):807-812.

Hargreaves KM, Stewart RJ, Oliver SR. Informed choice and public health screening for children: the case of blood spot screening. Health Expect. 2005;8(2):161-171. doi: 10.1111/j.1369-7625.2005.00324.x.

Gourounti K, Sandall J. The validation and translation of multidimensional measure of informed choice in Greek. Midwifery. 2011;27:170-173. doi: 10.1016/j.midw.2009.04.006.

Gourounti K, Sandall J. Do pregnant women in Greece make informed choices about antenatal screening for down's syndrome? A questionnaire survey. Midwifery. 2008;24(2):153-162. doi: 10.1016/j.midw.2006.09.001.

Alio AP, Lewis, CA, Scarborough K, et al. A community perspective on the role of fathers during pregnancy: A qualitative study. BMC Pregnancy and Childbirth. 2013;13(1):60. doi: 10.1186/1471-2393-13-60.

Nicholls, S., Southern, K. Informed choice for newborn blood spot screening in the United Kingdom: A survey of parental perceptions. Pediatrics. 2012;130:1527-1533. doi: 10.1542/peds.2012-1479.

Kemper AR, Fant KE, Clark SJ. Informing Parents about Newborn Screening. Public Health Nurs. 2005;22:332-338. doi: 10.1111/j.0737-1209.2005.220408.x.

Tluczek A, Orland KM, Nick SW, Brown RL. Newborn screening: an appeal for improved parent education. J Perinat Neonatal Nurs. 2009;23(4):326-334. doi: 10.1097/JPN.0b013e3181a1bc1f.

Jansen ME, Van Den Bosch LJ, Hendriks MJ, et al. Parental perspectives on retention and secondary use of neonatal dried bloodspots: A Dutch mixed methods study. BMC Pediatrics. 2019;19:1-11. doi: 10.1186/s12887-019-1590-8.

Clayton EW. Talking with parents before newborn screening. J Pediatr. 2005;147(3):26-29. doi: 10.1016/j.jpeds.2005.08.001.

IJzebrink A, van Dijk T, Franková V, et al. Informing Parents about Newborn Screening: A European Comparison Study. Int J Neonatal Screen. 2021;202;7(1):13. doi: 10.3390/ijns7010013.

Fitzgerald C., Heery E, Conneally, et al. An evaluation of pregnant women's knowledge and attitudes about newborn bloodspot screening. Midwifery. 2017;45:21-27. doi: 10.1016/j.midw.2016.11.007.

Campbell E, Ross L. Incorporating newborn screening into prenatal care. Am J Obstet Gynecol. 2004;190(4):876-877.

Franková V, Dohnalová A, Pešková K, et al. Factors Influencing Parental Awareness about Newborn Screening. Int J Neonatal Screen. 2019;5(3):35. doi: 10.3390/ijns5030035.

Downloads

Published

2023-03-30

How to Cite

David, A., Cruz, M. O., Telega, G., Simpson, P., Pan, A., & Nagórska, M. (2023). Newborn blood spot screening – knowledge of genetic testing among mothers. European Journal of Clinical and Experimental Medicine, 21(1), 52–57. https://doi.org/10.15584/ejcem.2023.1.7

Issue

Vol. 21 No. 1 (2023)

Section

ORIGINAL PAPERS

License

Copyright (c) 2023 European Journal of Clinical and Experimental Medicine

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Our open access policy is in accordance with the Budapest Open Access Initiative (BOAI) definition: this means that articles have free availability on the public Internet, permitting any users to read, download, copy, distribute, print, search, or link to the full texts of these articles, crawl them for indexing, pass them as data to software, or use them for any other lawful purpose, without financial, legal, or technical barriers other than those inseparable from having access to the Internet itself.

All articles are published with free open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0). If you submit your paper for publication by the Eur J Clin Exp Med, you agree to have the CC-BY license applied to your work. Under this Open Access license, you, as the author, agree that anyone may download and read the paper for free. In addition, the article may be reused and quoted provided that the original published version is cited. This facilitates freedom in re-use and also ensures that Eur J Clin Exp Med content can be mined without barriers for the research needs.

Most read articles by the same author(s)